Cardioprotective effect of resveratrol in myocardial ischemia/reperfusion injury and myocardial infarction: a pre-clinical meta-analysis in animal studies. [PDF]
PeerJWei SJ +7 more
europepmc +1 more source
Efficacy and safety of Traditional Chinese Medicine injections for no-reflow or slow flow in patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis. [PDF]
Front Cardiovasc MedCai T +6 more
europepmc +1 more source
Predictive Value of Apelin-36 for No-Reflow Phenomenon in STEMI Patients. [PDF]
Life (Basel)Krasniqi X +9 more
europepmc +1 more source
No-Reflow During Coronary Interventions: A Narrative Review. [PDF]
J Clin MedMalakouti S +3 more
europepmc +1 more source
Reconsidering the CHA2DS2-VASc Score for No-Reflow Risk Stratification after Percutaneous Coronary Intervention. [PDF]
Arq Bras CardiolSahin I, Deniz MF.
europepmc +1 more source
Numerical Modelling of Pulsed Laser Surface Processing of Polymer Composites. [PDF]
Materials (Basel)Szabliński K, Moraczewski K.
europepmc +1 more source
Assessment of No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Vessel. [PDF]
Cardiol ResHammad MAM +5 more
europepmc +1 more source
Thrombogenicity and the No-Reflow Phenomenon in STEMI: A Step Toward Personalized Intervention. [PDF]
JACC AsiaApostolos A.
europepmc +1 more source
Serum IL-1β as a Novel Predictor of No-Reflow in STEMI Patients Undergoing Primary PCI. [PDF]
J Inflamm ResWang S +5 more
europepmc +1 more source
Outcomes of High-Dose Intracoronary Adenosine Protocol in Saphenous Venous Graft Percutaneous Coronary Intervention: A 15-Year Single-Center Experience. [PDF]
J Soc Cardiovasc Angiogr IntervTahirkheli N +14 more
europepmc +1 more source